1,5-anhydroglucitol has been researched along with Chronic Illness in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bando, Y; Kanehara, H; Kasayama, S; Koga, M; Mukai, M; Murai, J; Saito, H; Tanaka, N; Toya, D | 1 |
| Kim, WJ; Lee, KB; Lee, WY; Oh, KW; Park, CY; Park, SE; Park, SW; Rhee, EJ | 1 |
2 other study(ies) available for 1,5-anhydroglucitol and Chronic Illness
| Article | Year |
|---|---|
1,5-Anhydroglucitol levels are low irrespective of plasma glucose levels in patients with chronic liver disease.
Topics: Blood Glucose; Case-Control Studies; Chronic Disease; Deoxyglucose; Diabetes Complications; Female; Humans; Liver Diseases; Male; Middle Aged; Multivariate Analysis; Regression Analysis | 2011 |
Serum 1,5-anhydroglucitol concentrations are a reliable index of glycemic control in type 2 diabetes with mild or moderate renal dysfunction.
Topics: Blood Glucose; Chronic Disease; Cross-Sectional Studies; Deoxyglucose; Diabetes Mellitus, Type 2; Glomerular Filtration Rate; Humans; Kidney Diseases | 2012 |